GlassScriptPhysician profile
Lennon Ndi
NPI 1760993844
$3,291.24
in general payments reported to CMS, 2019-2025
25 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $394 · 2022: $204 · 2023: $248 · 2024: $2,131 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,507 · Food and Beverage: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,507.30 |
| Food and Beverage | $1,185.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $977.70 | 2024 | |
| Rattan and Associates | $785.97 | 2024 | |
| Smith+Nephew, INC. | $261.76 | 2022-2025 | Stravix, Grafix, Oasis |
| Pacira Therapeutics, INC. | $223.60 | 2021 | |
| Stryker Corporation | $202.67 | 2021-2023 | Alphavent, Cinchlock |
| Depuy Synthes Sales INC. | $96.44 | 2024-2025 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $93.21 | 2022-2025 | Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $81.99 | 2023-2025 | Euflexxa |
| Bioventus LLC | $58.31 | 2023-2025 | Durolane, Xcell, Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $51.97 | 2024-2025 | Physio-Stim |
| Amgen INC. | $48.83 | 2021-2024 | Prolia, Evenity |
| Abbvie INC. | $48.02 | 2022 | |
| Baudax Bio INC. | $47.18 | 2021-2022 | |
| Tactile Systems Technology INC | $42.35 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $39.27 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $38.97 | 2025 | Xiaflex |
| Solventum Corporation | $33.46 | 2025 | Activ.A.C. |
| Kowa Pharmaceuticals America, INC. | $31.35 | 2022-2023 | Seglentis |
| Heron Therapeutics, INC. | $28.31 | 2021 | |
| Nalu Medical, INC. | $22.47 | 2023 | Nalu Neurostimulation System |
| Kerecis Limited | $18.05 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Anika Therapeutics, INC. | $17.58 | 2023 | Tactoset |
| Horizon Therapeutics Plc | $15.86 | 2021 | |
| Merck Sharp & Dohme LLC | $13.21 | 2024 | Bridion |
| Advanced Oxygen Therapy INC. | $12.71 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lennon Ndi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.